The article focuses on the use of beta-blockers such as bisoprolol, carvedilol and metoprolol succinate to reduce morbidity and mortality in systolic heart failure patients. It states that the Carvedilol or Metoprolol European Trial (COMET) found the carvedilol is better at extending survival than ...
Murin J, Ghanem WMIst Department of Internal Medicine, Medical Faculty, Comenius University and University Hospital, Bratislava,Slovakia.Ossamasleiman@hotmail.comAbstractThe problem of heart failure (HF) has become a topic of great interest. Until recently, the use of beta-blockers in ...
: Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 2000, 102:546–551. PubMed CAS Google Scholar Download references...
The role of beta-blockers in the management of patients with heart failure. (2001) The role of beta-blockers in the management of patients with heart failure. Dimensions of Critical Care Nursing 20 , 24-29 /... EM Maccallum - 《Dimensions of Critical Care Nursing Dccn》 被引量: 6发表...
The value of various therapeutic interventions should be based on proven effect in women and not on an assumption based on proven benefit in men. Among the medications currently recommended for patients with systolic heart failure, beta-blockers have the strongest data supporting their efficacy in ...
C Bavishi,S Chatterjee,S Ather,D Patel,FH Messerli 摘要: Beta-blockers are established drugs in heart failure with reduced ejection fraction, but their role in heart failure with preserved ejection fraction (HFpEF) is not established. Hence, we undertook a meta-analysis to evaluate the ...
Beta-blockers have become one of the cornerstones of treatment of patients with heart failure (HF) and depressed left ventricular function, but in clinical practice only 30-35 % of patients achieve the therapeutic target dose as established in randomized clinical trials. Mo...
Although evidence based guidelines recommend optimal use of beta blockers in all patients with chronic heart failure unless contraindicated, they are often underutilized and/or prescribed below the recommended dosage in the majority of patients with heart failure. To our knowledge, however, the optimal...
Heart rate control using beta-blockers for heart failure with atrial fibrillation: more than enough is too much. Hypertens Res 42, 1826–1827 (2019). https://doi.org/10.1038/s41440-019-0303-x Download citation Received22 June 2019 Revised03 July 2019 Accepted03 July 2019 Published30 July ...